| abstract |
This is related to Janus kinase (JAK) 3- [4- (7H-pyrrolo [2,3-d] pyrimidin-4-yl) -1H-pyrazol-1-yl] octanonitrile or 3- [ 4- (7H-pyrrolo [2,3-d] pyrimidin-4-yl) -1H-pyrazol-1-yl] heptanonitrile, and its pharmaceutically acceptable salts, as well as with its compositions, method of preparation and uses in treatment of diseases associated with JAK including, for example, inflammatory and autoimmune disorders, skin disorders, cancer and other diseases. |